February 27, 2020 / 1:00 PM / a month ago

BRIEF-Amphastar Pharmaceuticals Receives FDA Approval For Supplement To Its Abbreviated New Drug Application For Sodium Bicarbonate Injection

Feb 27 (Reuters) - Amphastar Pharmaceuticals Inc:

* AMPHASTAR PHARMACEUTICALS RECEIVES FDA APPROVAL FOR SUPPLEMENT TO ITS ABBREVIATED NEW DRUG APPLICATION FOR SODIUM BICARBONATE INJECTION, USP 8.4%, 50MEQ/50ML Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below